Mealey's (June 18, 2024, 2:39 PM EDT) -- BOSTON — A Massachusetts federal judge on June 17 signed off on the dismissal of five counts of mail fraud against a subsidiary of opioid XE "opioid" manufacturer Insys Therapeutics Inc. as part of the deferred prosecution agreement (DPA) that the parties reached in June 2019....